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Summary. The formation of 0 6-methyldeoxyguanosine 
(06-MedGuo) was determined by an immuno-slot-blot 
assay in DNA of various tissues of F344 rats exposed to 
N-methyl-N-nitrosourea (MNU) in the drinking waterat 
400 ppm for 2 weeks. Although the pyloric region of the 
glandular stomach is a target organ under these experi-
mental conditions, the extent of DNA methylation was 
highest in the forestomach (185 J.!mol 0 6-MedGuojmol 
guanine). Fundus (91 J.!moljmol guanine) and pylorus 
(105 J.!moljmol guanine) of the glandular stomach, 
oesophagus (124 J.!moljmol guanine) and duodenum 
(109 )lmoljmol guanine) showed lower Ievels of 0 6 -
MedGuo but differed little between each other. Thus, no 
correlation was observed between target organ specificity 
and the extent of DNA methylation. This is in contrast 
to the gastric carcinogen, N-methyl-N'-nitro-N-nitroso-
guanidine (MNNG), which preferentially alkylates DNA 
of the pylorus, the main site of induction of gastric carci-
nomas by this chemical. In contrast to MNU, the non-
enzymic decomposition of MNNG is accelerated by 
thiol compounds (reduced glutathione, L-cysteine), 
which are present at much higher concentrations in the 
glandular stomach than in the forestomach and oesopha-
gus. During chronic exposure to MNNG (80 ppm), mu-
cosal cells immunoreactive to 0 6-MedGuo are limited to 
the luminal surface [Kobori et al. (1988) Carcinogenesis 
9:2271-2274]. Although MNU (400 ppm) produced simi-
lar Ievels of 0 6-MedGuo in the pylorus, no cells contain-
ing methylpurines were detectable by immunohistochem-
istry, suggesting a more uniform methylation of mu-
cosal cells by MNU than by MNNG. After a single 
oral dose of MNU (90 mgjkg) cells containing methyl-
purines were unequivocally identified using antibodies to 
0 6-MedGuo and the imidazole-ring-opened product of 
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7-methyldeoxyguanosine. In the gastric fundus, their dis-
tribution was similar to those methylated by exposure to 
MNNG, whereas the pyloric region contained immu-
noreactive cells also in the deeper mucosallayers. After 
a 2-week MNU treatment, the rate of cell proliferation, 
as determined by bromodeoxyuridine immunoreactivity, 
was only slightly enhanced in the oesophagus andin the 
fundus, but markedly in the forestomach and the pyloric 
region of the glandular stomach. lt is concluded that the 
overall extent of DNA methylation, the distribution of 
alkylated cells within the mucosa and the proliferative re-
sponse all contribute to the organ-specific carcinogenic-
ity ofMNU. 
Key words: Gastric carcinogenesis - N-methyl-N-ni-
trosourea- DNA methylation 
Introduction 
The target organ specificity of N-methyl-N-nitrosourea 
(MNU) largely depends on the route of administration. 
A single systemic (i.v.) dose induces neoplasms in various 
tissues (Druckrey et al. 1967; Murthy et al. 1973) whereas 
chronic i. v. administration Ieads to the preferential in-
duction of brain tumours in rats (Druckrey et al. 1964, 
1965). I t has been reported that chronic administration of 
MNU in the drinking water induced forestomach tu-
mours in BD and Donryu rats (Druckrey et al. 1961; 
Ogiu et al. 1977). More recently, it has been shown that 
MNU also induces a high incidence of carcinomas in the 
pyloric region of the glandular stomach when given to 
F344 rats continuously in the drinking water (Maekawa 
et al. 1985; Hirota et al. 1987; Fujita et al. 1989). The site-
specific induction of gastric carcinomas by MNU is a 
somewhat surprising observation since MNU acts as a 
methylating agent after non-enzymatic hydrolysis and 
chemical (earrangements to rthe methyldiazonium ion. lts 
relative stability in vivo allows for homogeneaus systemic 
distribution (Kleihues and Patzschke 1971), with similar 
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Ievels of DNA methylation in different tissues (Kleihues 
and Magee 1973). In contrast, the decomposition of the 
gastric carcinogen N-methyl-N -nitro-N-nitrosoguanidine 
(MNNG) is enhanced by thiols (Lawley and Shah 1972; 
Wheeler and Bowdon 1972) which have been shown to 
occcur at higher concentrations in the glandular stomach 
than in the ri:lore proximal Segments of the gastrointesti-
nal tract (Boyd et al. 1979; Wiestieret al. 1983). Further-
more, MNU is, unlike MNNG, stable under acidic con-
ditions in gastric juice (Druckrey et al. 1967; McKay and 
Wright 1947). Thus, the mechanisms of gastric tumour 
induction by MNU and MNNG appear tobe different. 
The target organ specifity for genotoxic carcinogens 
is based primarily on the Ievel of DNA darnage in the 
proliferative cells. The aim of the present study was, 
therefore, to investigate DNA methylation (concentra-
tion and distribution), the rate of cell proliferation, and 
the hyperplastic responsein various parts ofthe gastroin-
testinal tract of the rats during chronic administration of 
MNU in the drinking water. An immuno-slot-blot assay 
(Nehls et al. 1984; Ludeke and Kleihues 1988) was used 
to determine the concentration of 0 6-methyldeoxygua-
nosine (06-MedGuo). In addition, cells containing meth-
ylpurines were identified immunohistochemically using 
antibodies to 0 6-MedGuo and the imidazole ring-
opened form of 7-methyldeoxyguanosine (7-MedGuo). 
Proliferating cells were identified by immunocytochemis-
try for bromodeoxyuridine (BrdU rd). 
Materials and methods 
Carcinogens. MNU (stabilized with acetic acid) and MNNG were 
purchased from Sigma (St. Louis, USA) and Fluka Chemie AG 
(Buchs, Switzerland), respectively. Tenfold stock solutions ofMNU 
were prepared in distilled water (4000 ppm) and kept at 4° C under 
light protection. For animal studies, it was diluted with distilled 
water immediately before use. Drinking solutions were changed 
daily except on weekends. The stability of the MNU solution before 
and after use was determined by measuring the absorbance at 
231 nm on a Hewlett Packard spectrophotometer. 
Anima/experiments. Y oung male F344 rats (1 00-150 g body weight) 
were purchased from Savo GmbH Kisslegg (FRG), housed four to 
a cage in macrolone cages and maintained on a basal diet (NAFAG 
890.1664, NAFAG, Gossau, Switzerland). A group of20 rats were 
given MNU in the drinking water ( 400 ppm) ad libitum. After treat-
ment for 2 weeks, rats were sacrified and brain, oesophagus, duode-
n um, colon, liver, and stomach (forestomach, pylorus and fundus of 
the glandular stomach) were removed. Organs from 10 rats were 
frozen separately in liquid nitrogen and kept at -80° C. For immu-
nohistochemical studies, organs from 5 rats were frozen on solid 
C02 and kept at -80° C until staining. Five rats were injected i.p. 
with BrdUrd (20 mg/kg) 1 h before sacrifice and organs were fixed 
in 70% ethanol (v/v) for 2 h. Two control rats were similarly in-
jected with BrdUrd. Two rats were treated with a single dose of 
MNU (1.5 ml, 90 mg/kg body weight; 50% ofLD50) or MNNG So-
lution (2.0 ml 83 ppm solution; 1.3 mg/kg body weight) by instilla-
tion in the upper oesophagus. After 2 h, rats were killed and or-
gans were removed as described above for immunohistochemistry. 
Body weight, water consumption and carcinogen intake. The mean 
body weights of rats chronically exposed to MNU decreased about 
15% during the first week oftreatment but remained stable the sec-
ond week of treatment. The water consumption per rat was, on the 
average, 7.6 ml/day. During the first week, the mean concentration 
of the MNU solution (pH 4.5), as calculated from the UV absor-
bance before and after application, was 320 ppm. Since the body 
weight decreased during the first week, the pH of the drinking solu-
tionwas adjusted by NaOH to 6-7 during the second week, which 
resulted in a morerapid decay of MNU. Under these conditions the 
calculated mean concentration of the MNU solution was 130 ppm. 
The daily MNU intake, calculated from water consumption and 
MNU concentrations, was 11.9 mg/kg body weight/day. 
Jmmuno-slot-blot assay. The characteristics of the rabbit antiserum 
to 0 6-MedGuo (NPZ193-1) and of the alkylated DNA standards 
have been described previously (Ludeke and Kleihues 1988). DNA 
was purified by phenol extraction using a nucleic acid extractor 
(model340A; Applied Biosystems, Foster City, Calif. 94404, USA). 
Since the amounts of DNA obtained from some tissues (oesoph,a-
gus, forestomach, pylorus) were too small to allow for individual 
analysis, the organs from two groups of 5 animals each were pooled 
before DNA isolation (Table 1). To test the individual differences in 
the Ievels of 0 6 -MedGuo, triplicate analyses were carried out on 
fundus and liver of rats given MNU for 2 weeks. Inter-individual 
values for 0 6-MedGuo differed by less than 30% and the standard 
deviation was less than 20% of the mean. 
Details of the immuno-slot-blot assay were described earlier 
(Ludeke and Kleihues 1988). Briefly, DNA samples (9j.i.g in 300 J..tl) 
were heat-denatured for 10 min in boiling water, quickly chilled on 
ice, and mixed with an equal volume of 2M ammonium acetate. 
DNA was immobilized on nitrocellulose filters (BA 85, Schleicher 
and Schüll). Filters were presoaked in 1M ammonium acetate and 
3 j.lg DNA in 200 j.i.l was applied to each weil. After rinsing each well 
with 200 f..ll 1M ammonium acetate, filters were removed from the 
support. Thefilters were soaked in 0.75 M NaCI, 0.075 Mtrisodium 
citrate for 5 min, blow-dried and baked at 80° C for 2.5 h. After 
blocking non-specific protein-binding sites with 0.5% casein in 
phosphate-buffered saline (PBS: 140 mM NaCI, 2.7 mM KCI, 
8.1 mM Na 2HP04 2H20, and 1.5 mM KH 2P04 , pH 7.2}"at 37° C 
for 30 min, the filters were incubated overnight at 4o C with anti~ 
0 6MedGuo antibody diluted 1:8000 in the samc buffer. The filters 
were subsequently washed three times in casein buffer, once in high-
saline PBS (PBS-HS), and once in PBS-HS containing 0.05% 
Nonidet P-40 (Sigma), allowing 10 min for each buffer change. 
Then, filters were incubated with goat anti-(rabbit lgG}--alkaline-
phosphatase conjugate (Bio-Rad, Richmond, Calif.), diluted 1:3000 
in PBS containing 0.5% casein for 3 hat room temperature. The ni-
trocellulose filters were then washed as above. Enzymatic activity 
was visualized by incubation for 10-20 min in a solution of 5-
bromo-4-chloro-3-indolyl phosphate toluidine salt (Bio-Rad, Rieb-
mond, Calif.) ~-~.nd p-nitroblue tetrazolium chloride (Bio-Rad, Rieb-
mond, Calif.) in diethanolamine buffer (0.1 M NaCI, 0.1 M TRIS, 
25.0 mM diethanolamine, 2.0 mM MgC12, and 1.0 J..tM ZnC12 , 
pH 9.55) at 37o C according to Ey and Ashman (1986). The filters 
were subsequently rinsed extensively with distilled water and stored 
wet in the dark until densitometry. Densitometric evaluationwas 
performed using a Shimadzu model CS-930 dual-wavelength thin-
layer chromatogram scanner in the zig-zag mode at 530 nm. 
lmmunohistochemistry jor alkylated DNA bases. The polyclonal 
antibody to 0 6-MedGuo was the sameasthat used in the immuno-
slot-blot assay. A monoclonal antibody to 7-MedGuo (Montesano 
et al. 1988) was kindly provided by Dr. Christopher Wild, "Interna-
tional Agency for Research on Cancer, Lyon, France. The immuno-
histochemical reaction used (Koenigsmann et al. 1988) was a mod-
ification of the procedure described by Menkveld et al. (1985). 
Briefly, cryostat sections (6-10 J..tm) were mounted on slides that 
were coated with 3-aminopropylmethoxysilane. Endogenous 
peroxidasewas inactivated by a 45-min incubation with 0.3% H20 2 
in methanol. After dehydration, sections were incubated with 
10 mM EDT A and 10 mM TRIS, pH 8.0, for 5 min and subsequently 
treated with RNase A (200 J..tg/ml; Sigma, St. Louis, USA) and 
RNase T 1 (50 U/ml; Boehringer Mannheim, FRG) in the same 
buffer for 60 min at 37o C. Sections were rinsed with distilled water 
and fixed with 40% ethanol for 1 min, then treated with 50 mM 
NaOH for 10 min in 40% ethanol to denature DNA. After neu-
tralizing with 5% glacial acetic acid in 40% ethanol and washing 
with water, sections were incubated for 5 min in wash buffer 
(50 mM TRIS, pH 7.4, 150 mM NaCl, 5 mM EDTA, 0.25% gela-
tine), and rinsed with PBS. The sections were subsequently pre-incu-
bated (60 min, 37o C) with antibody-dilution buffer (1 0% heat-inac-
tivated non-immune swine serum in PBS). The reaction with the 
anti-06-MedGuo or anti-7-MedGuo serum (diluted 1:10000 or 
15000, respectively) was carried out for 16 hat 4° C. Bound anti-
hodies were detected by the double PAP procedure (Ordronneau et 
al. 1981), which involved successive incubations with swine anti-
(rabbit Ig), perox.idase-(rabbit)antiperoxidase complex, swine anti-
(rabbit Ig) and peroxidase-(rabbit)antiperoxidase complex, each 
carried out for 30 min at room temperature. Enzymatic activity was 
visualised by incubation in 0.035% 3,3-diaminobenzidine · 4HC1 in 
50 mM TRIS/HCI, pH 7.4, containing 0.015% H 20 2 for 5-10 min 
at room temperature. 
BrdUrd immunohistochemistry. The immunohistochemical tech-
nique was essentially that described previously (Ohgaki et al. 1988). 
Briefly, paraffin sections were deparaffinized in xylene and placed 
in absolute ethanol. Endogenausperoxidase activity was blocked by 
incubating them for 30 min in 0.3% H20 2 in methanol. The sections 
were washed with distilled water and then incubated in 2M HCl for 
30 min. Neutralization was done by incubation in 0.1 M Na2 B4 0 7 
for 10 min. The sections were treated with 10% normal swine serum 
and then incubated with anti-BrdUrd monoclonal antibody (diluted 
1 :20; Becton Dickinson, Basel, Switzerland) for 2 h at room temper-
ature. After this and following the incubation steps, the sections 
were washed three times with PBS (pH 7.4). The sections were incu-
bated with biotinylated anti-(mouse-IgG) (diluted 1:100; Amers-
ham, UK) for 30 min and then avidin-biotin-peroxidase complex 
(DAKO, Denmark) for 30 min. Sections were developed in 0.05% 
3,3-diaminobenzidine·4HCl in 50 mM TRIS/HCI buffer (pH 7.4) 
containing 0.03% H 20 2 for 5-10 min at room temperature. The sec-
tions were stained lightly with haematoxylin and examined histo-
logically. 
Results 
Histopathology and cell proliferation 
after 2 weeks of exposure to MNU 
After treatrnent with MNU for 2 weeks (400 pprn in the 
drinking water), the oesophageal epitheliumwas slightly, 
and that of the forestarnach severely hyperplastic, with 
concornitant hyperkeratosis. Cell proliferation in the 
oesophagus was slightly enhanced whereas that in the 
forestarnach was prominently increased when compared 
to untreated control rats. No histological changes were 
found in the fundie region of the glandular stomach, but 
in the pyloric region, erosion, elongation of pits, and ir-
regular arrangement of glands were present in all rats 
given MNU for 2 weeks. A slight increase in the fraction 
.of BrdUrd-labelled cells was observed in the fundiere-
gion but this was rnuch rnore pronounced in the pylorus. 
In the duodenurn, a slight elongation of villi was found, 
together with a slight increase in the number of proliferat-
ing cells. No histological changes were detected in colon, 
liver or brain. 
Formation of 0 6-MedGuo 
Significant amounts of 0 6-MedGuo were found in all or-
gans of rats that were given MNU for 2 weeks (Table 1 ). 
DNA rnethylation was highest in the brain. Within the 
15 
Table 1. Organ-specific Ievels of 0 6-MedGuo in DNA in rats given 
N-methyl-N-nitrosourea (MNU) in the drinking water (400 ppm) 
for 2 weeks 8 
Organ 0 6-MedGuo (mol/mol guanine) 
Group 1 Group 2 Mean 
Oesophagus 114 134 124 
Forestarnach 197 172 185 
Glandular stomach 
Fundus 87 94 91 
Pylorus 97 112 105 
Duodenum 103 116 109 
Colon 62 55 59 
Li ver 36 23 29 
Brain 230 226 228 
a The organs from two groups of 5 animals each were pooled 
before DNA isolation. To test the individual differences in the Ievels 
of 0 6-MedGuo, triplicate analyses were carried out on fundus and 
liver of rats given MNU for 2 weeks. Inter-individual values for 
0 6-MedGuo differed by less than 30% and the standard deviation 
was less than 20% of the mean 
gastrointestinal tract, forestarnach showed highest Ievels 
of rnethylation. Concentrations of 0 6-MedGuo in 
oesophagus, pylorus, fundus, and duodenum were lower 
but differed little fröm each other. Colon and liver 
showed the lowest amounts of 0 6-MedGuo. 
Immunohistochemical identification 
of cells containing methylpurines 
After 2 weeks of exposure to MNU in the drinking water, 
no irnmunoreactivity was detectable in any of the tissues 
examined. In contrast, in rats given a single high dose öf 
MNU (90 rng/kg body weight), surface epithelia of the 
fundus and pylorus of the glandular stomach were 
stained intensely by the anti-06-MedGtio and anti-7-
MedGuo antibodies. In gastric fundus, the population of 
cells stained with anti-06-MedGuo and anti-7-MedGuo 
antiborlies was limited to the luminal surface (Fig.1a) 
whereas in the pylorus, deeper mucosal layers also 
showed unequivocal immunoreactivity (Fig. 1 b ). There 
were no positive cells in the other organs of rats given a 
single dose of MNU. For comparison, two rats were 
given a single dose of MNNG (1.3 mg/kg) by instillation 
in the upper oesophagus. Cells staining for 0 6 -MedGuo 
and 7-MedGuo were observed in the surface epithelium 
of both the fundie and pyloric region of the glandlilar 
stomach (Fig.tc, d). 
Discussion 
Induction of gastric carcinomas by MNNG and its ethyl 
analogue, N-ethyl-N-nitro-N-nitrosoguanidine consti-
tutes the major anirnal model that has been studied exten-
sively in various laboratories (Ohgaki and Sugimura 
1988). In rats, chronic exposure to MNNG in the drink-
ing water induces a high incidence of carcinomas in the 
pyloric region of the glandular stomach, less frequently in 
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Fig.l a-d. Immunohistochemical demonstration of 0 6-MedGuo in the fundie and pyloric mucosa of F344 rats following a singleoral dose 
of 90 mg/kg N-methyl-N-nitrosourea (MNU) (a, b) and 1.3 mgjkg N-methly-N -nitro-N-nitrosoguanidine (MNNG) (c, d). In the fundus, the 
population ofcells stained with anti-06 -MedGuo was limited to the luminal surface after administration ofboth MNU (a) and MNNG (c). 
Note that in the pyloric mucosa, immunoreactivity following MNNG administration is restricted to a smalllayer of cells bordering the Iumi-
na) surface (d), whereas after administration of MNU, the pyloric region contains immunoreactive cells also in the deeper mucosallayers 
(b). Normarski interference contrast microscopy ( x 250) 
the fundus and duodenum, and rarely in the other organs 
(Ohgaki and Sugimura 1988). Recently, it has been re-
ported that MNU also induces gastric carcinomas when 
given in the drinking water in F344 rats. According to 
Maekawa et al. (1985), gastric carcinomas develop in 
about 40% of F344 rats exposed to MNU at a concentra-
tion of 100 ppm in the drinking water for 42 weeks. 
Hirota et al. (1987) reported that gastric carcinomas were 
selectively induced in 100% of F344 rats that were given 
MNU in the drinking water (400 ppm) for 25 weeks and 
then maintained without carcinogen for a further 
20 weeks. Later, these authors found that administration 
of MNU at 100 ppm for 15 weeks followed by 25 weeks 
without carcinogen was an optimal condition for the se-
lective induction of gastric carcinomas in F344 rats with-
out significant toxicity (Fujita et al. 1989). 
In the present experiment oral administration of 
MNU for 2 weeks produced significant amounts of 0 6 -
MedGuo in all rat tissues examined and no correlation 
was found between target organ specificity and the extent 
of DNA methylation. Highest amounts of 0 6-MedGuo 
were found in the brain. This is due to the low activity of 
the repair enzyme, 0 6-methylguanine DNA methyltrans-
ferase in the central nervous system (Kleihues and Margi-
son 1974; Margison and Kleihues 1975) and correlates 
with the high incidence ofbrain tumours in F344 rats fol-
lowing chronic oral MNU administration (Maekawa et 
al. 1985). In the digestive tract, the forestarnach showed 
a greater extent of DNA methylation than the other tis-
sues, and oesophagus, pylorus and fundus of the glandu-
lar stomach and duoden um showed lower Ievels of 0 6 -
MedGuo but they differed little between each other. This 
is in contrast to similar sturlies with MNNG, which 
showed 0 6-MedGuo concentrations in the glandular 
stomach tobe ten and four tirnes higher than in forestarn-
ach and duodenum, respectively (Wiestler et al. 1983; 
Kobori et al. 1988). The high Ievel of methylation in 
DNA ofthe target organ (glandular stomach) appears to 
be due to the presence ofthiols. SH compounds (e.g. cys-
teine and reduced glutathione) aceeierate the non-en-
zymatic decomposition and rnacromolecular binding of 
MNNG. In rats, concentrations of free thiols are consid-
erably higher in the glandular stomach than in the 
oesophagus and forestarnach (Boyd et al. 1979; Wiestier 
et al. 1983). At the same time, MNNG is rapidly de-
graded at the low pH of gastric juice (McKay and Wright 
1947). This could explain the lower Ievels ofmethylation 
in duoden um, ileum and colon despite the high thiol con-
centration in these tissues (Boyd et al. 1979; Wiestier et 
al. 1983). In contrast, MNU is stable under the acidic 
conditions ofthe intragastric environment and its decom-
position to a methylating intermediate, i.e. methyldiazo-
nium hydroxide, is not affected by intracellular thiols. 
These characteristics might explain the widespread dis-
tribution of methylation in various tissues. 
There is indirect evidence that the distribution of cells 
containing methylpurines within the gastric mucosa also 
differs between MNU and MNNG. After chronic admin-
istration of MNNG (80 ppm), cells staining for 0 6-
MedGuo were restricted to the luminal surface of the 
glandular stomach (Kobori et al. 1988). The amounts of 
0 6-MedGuo in inbred Wistar rats given MNNG at 
80 ppm for 3-84 days were 50-100 J.Lmoljmol guanine in 
pylorus and 20-50 J..lmoljmol guaninein the fundus and 
duodenum, respectively (Kobori et al. 1988). Although 
chronic exposure to MNU ( 400 ppm) produced similar 
Ievels of 0 6-MedGuo in the pylorus and higher Ievels in 
other segments of the digestive tract of rats, no immu-
noreactive cells were detectable. This discrepancy is most 
likely due to a more uniform methylation of mucosal 
cells, i.e. the amounts of 0 6-MedGuo present in individ-
ual nuclei are lower than the immunohistochemical de-
tection Iimit. One explanation for a broader distribution 
17 
of cells contammg methylpurines is that intragastric 
MNU is not completely decomposed at the site ofuptake 
into the gastric mucosa. In contrast to MNNG, a signif-
icant fraction of MNU is resorbed and redistributed via 
the bloodstream (Swann and Magee 1968; Swann 1968). 
Our immunohistochemical sturlies showed that in rats 
given MNU as a singlehigh oral dose (90 mgjkg), cells 
containing methylpurirres were present in the surface ep-
ithelium ofthe fundus whereas, in the gastric pylorus, im-
munoreactivity to 0 6 -MedGuo and 7-MedGuo was also 
detectable in deeper layers of the mucosa. This phenom-
enon may explain the different susceptibility to MNU-in-
duced carcinogenesis of pylorus and fundus (Hirota et al. 
1987), i.e. tissues which in biochemical analysis showed 
similar levels of DNA methylation after administration 
of MNU for 2 weeks. If labeHing of the deeper mucosal 
layers were due to systemically distributed MNU, such 
regional differences between pylorus and fundus would · 
be unlikely to occur. It is more likely that MNU in the 
gastric Iumen reaches deeper layers in the pyloric glands 
than in the fundie glands. Although no attempt was made 
to quantify the immunohistochemical data, it appeared 
that the staining in the fundie region of rats after a single 
oral dose of90 mg MNU/kg was similar tothat seen after 
a 70-times lower dose of MNNG (1.3 mg/kg body 
weight). No labelled cells were detected in any tissue of 
a rat given 20 mg MNU/kg (data not shown). These re-
sults also support the view that thiols enhance gastric 
DNA methylation by MNNG but not by MNU. 
After a 2-week treatment with MNU, enhanced cell 
proliferation and histological changes were most pro-
nounced in the forestarnach and pylorus. Previous sturl-
ies have shown that changes in the proliferative activity 
on the gastric mucosa may play a crucial role in the ini-
tiation of neoplastic transformation by MNNG in rats 
(Ohgaki et al. 1988, 1989). The combined data of DNA 
methylation and DNA synthesis suggest that forestarn-
ach and pylorus of the glandular stomach are at the 
highest risk of mutation during MNU treatment in the 
drinking. water in F344 rats. However, resistance to 
MNU -induced carcinogenesis in the forestarnach of 
F344 rats also suggests that genetic factors could signifi-
cantly modulate MNU-induced gastric carcinogenesis in 
rats. 
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